Dr. Komrokji on Optimizing MDS Management

Rami S. Komrokji, MD
Published: Tuesday, Apr 14, 2015



Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses optimizing the management of treatment for myelodysplastic syndrome (MDS).

Because there are limited options approved for MDS, it is important that oncologists optimize treatment in order to achieve the best results, says Komrokji.

Biomarkers can be used to best select which treatment should be used first for MDS. It is also important to be familiar with the management, toxicities and response timelines for each treatment. This way, if a treatment is not working well, the physician can switch to a more optimal treatment regimen.

Komrokji says it is also important to determine the optimal time, if at all, to conduct a transplant. ​



Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses optimizing the management of treatment for myelodysplastic syndrome (MDS).

Because there are limited options approved for MDS, it is important that oncologists optimize treatment in order to achieve the best results, says Komrokji.

Biomarkers can be used to best select which treatment should be used first for MDS. It is also important to be familiar with the management, toxicities and response timelines for each treatment. This way, if a treatment is not working well, the physician can switch to a more optimal treatment regimen.

Komrokji says it is also important to determine the optimal time, if at all, to conduct a transplant. ​




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x